Gangrene cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Gangrene}} {{CMG}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Re..." |
|||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gangrene}} | {{Gangrene}} | ||
{{CMG}}; {{AE}} [[User:Edzelco|Edzel Lorraine Co, D.M.D., M.D.]] | |||
==Overview== | |||
[[Gangrene]] is a potential [[life-threatening condition]] if not given [[prompt treatment]]. Although the [[incidence]] is just low, [[gangrene]] can generate a high [[healthcare cost]]. | |||
==Cost-Effectiveness of Therapy== | |||
*[[Gangrene]] is a potential [[life-threatening condition]] if not given [[prompt treatment]]. Although the [[incidence]] is just low, [[gangrene]] can generate a high [[healthcare cost]]. | |||
*Factors that contribute to this high [[healthcare cost]] include the length of [[cost of hospital stay]], [[cost of surgical intervention]], and [[cost of medications]] needed.<ref name="pmid22445562">{{cite journal| author=Jiménez-Pacheco A, Arrabal-Polo MÁ, Arias-Santiago S, Arrabal-Martín M, Nogueras-Ocaña M, Zuluaga-Gómez A| title=Fournier gangrene: description of 37 cases and analysis of associated health care costs. | journal=Actas Dermosifiliogr | year= 2012 | volume= 103 | issue= 1 | pages= 29-35 | pmid=22445562 | doi=10.1016/j.adengl.2011.04.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22445562 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 02:05, 10 April 2022
|
Gangrene Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gangrene cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Gangrene cost-effectiveness of therapy |
|
Risk calculators and risk factors for Gangrene cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Gangrene is a potential life-threatening condition if not given prompt treatment. Although the incidence is just low, gangrene can generate a high healthcare cost.
Cost-Effectiveness of Therapy
- Gangrene is a potential life-threatening condition if not given prompt treatment. Although the incidence is just low, gangrene can generate a high healthcare cost.
- Factors that contribute to this high healthcare cost include the length of cost of hospital stay, cost of surgical intervention, and cost of medications needed.[1]
References
- ↑ Jiménez-Pacheco A, Arrabal-Polo MÁ, Arias-Santiago S, Arrabal-Martín M, Nogueras-Ocaña M, Zuluaga-Gómez A (2012). "Fournier gangrene: description of 37 cases and analysis of associated health care costs". Actas Dermosifiliogr. 103 (1): 29–35. doi:10.1016/j.adengl.2011.04.007. PMID 22445562.